||Charles PETITOT is appointed General Director of IRIS CONSEIL SANTE
||Cooperation agreement between IMPE and AP-HM
||IMPE and IRIS move into their new facility in Courbevoie (Paris La Défense)
||Thomas FERNANDEZ becomes the President of the IMPE Group
||The Arab Spring cause many delays in MEA projects
||Opening of an office in Benghazi to manage the Benghazi Medical Center Project
||Ideal Medical Products becomes Ideal Medical Products Engineering
||Takeover of SCIENT'X by U.S. investment fund Healthpoint. I.M.P. quotation in stock exchange is suspended.
||Increase from 73,58 to 94.19% of SCIENT'X participation in SURGIVIEW.
||A reinforcement of Ideal Medical Products skills in the fields of medical structure consultancy, strategy and organisation thanks to the acquisition of IRIS CONSEIL SANTE.
||The company further establishes its presence in Asia by opening the Malaysian office Ideal Medical Products SEA Sdn Bhd.
Acquisition of 50% of the company G.P.F (Gaz Purs & Fluides).
||The company is transferred onto the Second Stock Exchange Market.
||The company enters the Stock Exchange on the unofficial market. It is renamed Ideal Medical Products. It then furthers its development in Europe by opening the Greek office. SCIENT'X, a company specialised in the study, design and distribution of implantable prostheses made of titanium for orthopaedic surgery and neurosurgery, joins the group.
||The company branches out thanks to the acquisition of CETI, a Belgian company that designs and markets imaging systems for laboratories.
Well established in Eastern Europe and Russia, the company confirms its position by opening its own Russian office: Zao Ideal Products.
||13 January 1987, Ideal Products was founded, a company that designs, studies and implements medical projects.